Sanford launches clinical trial to destroy tumors
Sanford Health has launched a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.
Sanford Health has launched a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.
The results of a study by a Sanford Health researcher that found a new immunotherapy for advanced head and neck cancers were recently reported in the Journal of Clinical Oncology.